Cytek Investor Day Presentation Deck
Market Forces and Needs Shaping Cell Analysis
Research
Emergence of high dimensional
characterization & functional
assays
●
●
●
The rise of immunotherapy, tum or
microenvironment, infectious
disease studies (COVID)
In 2021 Flow Cytometry accounted
for the largest share of -29% of the
global cell analysis market
Target customers
Academic Institutions
Pharma & Biotech R&D
CYTEK
TRANSCEND THE CONVENTIONAL
Translational
CRO focus on cell markers and
biomarkers leads to new clinical
applications
Comprehensive Panels, New
Fluorochromes
Instrument Characterization,
Optimization, Standardization
Panel Construction, Optimization,
Validation, Automation
Data Analysis, Automated Analysis,
Cloud-based
Target customers
CRO, Pharma, Specialty labs
Performance (quality), price,
IVD, customer service are
fundamental needs
●
●
●
●
●
Clinical
●
Validated applications & assay kits
Understanding and adjusting to
changing clinical regulations
EU IVDR May 2022 (replacing IVDD)
Laboratory Developed Tests (LDT)
VALID Act proposed in US
congress to replace 510 K and LDT with
new category
Target customers
Reference labs, hospital labs
Developing country clinical labs
13View entire presentation